Skip to content
Home/Companies/Pharma/ProJect Pharmaceutics
ProJect Pharmaceutics

ProJect Pharmaceutics

Pharma·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns ProJect Pharmaceutics?

ProJect Pharmaceutics is a German Pharma company, currently owned by AFINUM Management GmbH since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
AFINUM Management GmbH
Investor
AFINUM Management GmbH
AFINUM IX Buyout (2021) · 2021 · Small-Mid Buyout

Key facts

HQGermany
SectorPharma
StatusActive
Websiteproject-pharmaceutics.com

More from AFINUM IX Buyout (2021)

Other portfolio companies in the same fund.

Fairbanks
Fairbanks
Active
SaaSNetherlands· 2026
DPS Engineering
Active
SaaSGermany· 2025
Ergon Informatik
Active
SaaSSwitzerland· 2025
sequrio
sequrio
Active
SaaSGermany· 2025
MedTech Laser Group
Active
MedTechGermany· 2024
Objektkultur Software
Objektkultur Software
Active
SaaSGermany· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns ProJect Pharmaceutics?

ProJect Pharmaceutics is currently owned by AFINUM Management GmbH, through AFINUM IX Buyout (2021), since 2025.

When did AFINUM Management GmbH acquire ProJect Pharmaceutics?

AFINUM Management GmbH acquired ProJect Pharmaceutics in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue